CFDE Data Portal | Search MTND2P40

	Label	Description
	MTND2P40 Gene (Entity type)	ENSG00000236483 - MT-ND2 pseudogene 40
	GSE195663 cisplatin 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE252944 AKT inhibition 3 v 6 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE207514 GSE207515 PI3K inhibition 0 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE115384 CELSR2 knockdown 6 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE178975 GSE178978 EGFR inhibition 1 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE100148 EZH2 inhibition 9 v 5 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE195663 cisplatin 0 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE252944 AKT inhibition 11 v 9 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE174036 tryptophan 2 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS

MTND2P40

ENSG00000236483 - MT-ND2 pseudogene 40

GSE195663 cisplatin 0 v 1 human up

A Gene Set from LINCS

GSE252944 AKT inhibition 3 v 6 human dn

A Gene Set from LINCS

GSE207514 GSE207515 PI3K inhibition 0 v 3 human up

A Gene Set from LINCS

GSE115384 CELSR2 knockdown 6 v 1 human up

A Gene Set from LINCS

GSE178975 GSE178978 EGFR inhibition 1 v 0 human up

A Gene Set from LINCS

GSE100148 EZH2 inhibition 9 v 5 human up

A Gene Set from LINCS

GSE195663 cisplatin 0 v 2 human up

A Gene Set from LINCS

GSE252944 AKT inhibition 11 v 9 human up

A Gene Set from LINCS

GSE174036 tryptophan 2 v 3 human up

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.